Rights and permissions
About this article
Cite this article
ADR costs driven by a few therapeutic drug classes. Pharmacoecon. Outcomes News 314, 8 (2001). https://doi.org/10.1007/BF03280349
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280349